Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand
- Investing News
admin
- 0
- 1 minute read
Moderna shares fell to an almost three-year low after the biotech firm reiterated its full-year guidance but warned it couldn’t yet predict COVID-19 vaccine demand.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-699097867-f28c270e43d14c50abccd9ce274471e6.jpg "<div>Nasdaq Market Maker vs. NYSE Specialist: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1909422439-a385ac4d36534f7d869d0aa4959d4e1b.jpg "An Overview of Annuities")
:max_bytes(150000):strip_icc():format(jpeg)/signing-6bd3c67514c149a3b78bda1b22e82d1e.jpg "Where to Get a Personal Loan Other Than a Bank")